9.46
+0.47
+(5.23%)
At close: January 10 at 4:00:00 PM EST
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul Kang | CEO, President & Director | -- | -- | 1962 |
| Ms. Jiyoung Hwang | CFO, Secretary & Director | -- | -- | 1977 |
| Mr. Joshua Miller | Chief Accounting Officer | -- | -- | 1976 |
Exicure, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Corporate Governance
Exicure, Inc.’s ISS Governance QualityScore as of November 1, 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 8; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 14, 2024 at 9:01 PM UTC
Exicure, Inc. Earnings Date
Recent Events
Related Tickers
PLRZ Polyrizon Ltd.
1.4700
-4.55%
WINT Windtree Therapeutics, Inc.
0.2552
-5.09%
GDTC CytoMed Therapeutics Limited
2.7600
+20.52%
TRAW Traws Pharma, Inc.
8.06
-0.12%
PRTG Portage Biotech Inc.
4.3700
-7.22%
APM Aptorum Group Limited
1.3900
-2.80%
FBRX Forte Biosciences, Inc.
17.78
-8.54%
PULM Pulmatrix, Inc.
6.01
+0.33%
VRPX Virpax Pharmaceuticals, Inc.
0.3650
-0.16%
TIL Instil Bio, Inc.
19.85
-9.77%